174 related articles for article (PubMed ID: 10086196)
1. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors.
Wahli W; Devchand PR; IJpenberg A; Desvergne B
Adv Exp Med Biol; 1999; 447():199-209. PubMed ID: 10086196
[No Abstract] [Full Text] [Related]
2. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
Kliewer SA; Sundseth SS; Jones SA; Brown PJ; Wisely GB; Koble CS; Devchand P; Wahli W; Willson TM; Lenhard JM; Lehmann JM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4318-23. PubMed ID: 9113987
[TBL] [Abstract][Full Text] [Related]
3. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
4. PPARs: nuclear receptors for fatty acids, eicosanoids, and xenobiotics.
Devchand PR; Ijpenberg A; Devesvergne B; Wahli W
Adv Exp Med Biol; 1999; 469():231-6. PubMed ID: 10667335
[TBL] [Abstract][Full Text] [Related]
5. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
Forman BM; Chen J; Evans RM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4312-7. PubMed ID: 9113986
[TBL] [Abstract][Full Text] [Related]
6. Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo.
Liu PC; Huber R; Stow MD; Schlingmann KL; Collier P; Liao B; Link J; Burn TC; Hollis G; Young PR; Mukherjee R
J Steroid Biochem Mol Biol; 2003 May; 85(1):71-9. PubMed ID: 12798359
[TBL] [Abstract][Full Text] [Related]
7. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Murakami K; Ide T; Suzuki M; Mochizuki T; Kadowaki T
Biochem Biophys Res Commun; 1999 Jul; 260(3):609-13. PubMed ID: 10403814
[TBL] [Abstract][Full Text] [Related]
8. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Berger J; Wagner JA
Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
[TBL] [Abstract][Full Text] [Related]
9. Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element.
Nunez SB; Medin JA; Keller H; Wang K; Ozato K; Wahli W; Segars J
Recent Prog Horm Res; 1995; 50():409-16. PubMed ID: 7740175
[No Abstract] [Full Text] [Related]
10. Effects of fatty acids on gene expression mediated by a member of the nuclear receptor supergene family.
Gustafsson JA; Gearing K; Widmark E; Tollet P; Strömstedt M; Berge RK; Göttlicher M
Prog Clin Biol Res; 1994; 387():21-8. PubMed ID: 7972247
[No Abstract] [Full Text] [Related]
11. [The role of fatty acids in gene regulation. An example of an important nutritional factor which may influence our genes].
Endresen MJ
Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2084-6. PubMed ID: 7644988
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids bind directly to and activate peroxisome proliferator-activated receptors alpha and gamma.
Wolf G
Nutr Rev; 1998 Feb; 56(2 Pt 1):61-3. PubMed ID: 9529901
[TBL] [Abstract][Full Text] [Related]
13. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
14. Genetics and molecular biology: peroxisome proliferator-activated receptor gamma still full of surprises.
Cullen P; Lorkowski S
Curr Opin Lipidol; 2002 Jun; 13(3):335-7. PubMed ID: 12045403
[No Abstract] [Full Text] [Related]
15. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
[TBL] [Abstract][Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases.
Dubuquoy L; Dharancy S; Nutten S; Pettersson S; Auwerx J; Desreumaux P
Lancet; 2002 Nov; 360(9343):1410-8. PubMed ID: 12424006
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T
Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators.
Hertz R; Seckbach M; Zakin MM; Bar-Tana J
J Biol Chem; 1996 Jan; 271(1):218-24. PubMed ID: 8550563
[TBL] [Abstract][Full Text] [Related]
19. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
20. Phytanic and pristanic acid are naturally occuring ligands.
Zomer AW; van der Saag PT; Poll-The BT
Adv Exp Med Biol; 2003; 544():247-54. PubMed ID: 14713238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
